Optimization of Important Early ADME(T) Parameters of NADPH Oxidase-4 Inhibitor Molecules

被引:3
|
作者
Borbely, Gabor [1 ,2 ]
Huszar, Monika [1 ]
Varga, Attila [1 ,2 ]
Futosi, Krisztina [4 ]
Mocsai, Attila [4 ]
Orfi, Laszlo [2 ,3 ,5 ]
Idei, Miklos [1 ]
Mandl, Jozsef [6 ]
Keri, Gyoergy [1 ,2 ,3 ]
Vantus, Tibor [1 ]
机构
[1] Semmelweis Univ, Dept Med Chem, Pathobiochem Res Grp, Hungarian Acad Sci, Budapest, Hungary
[2] Semmelweis Univ, Rat Drug Design Lab CRC, Budapest, Hungary
[3] Vichem Chem Res Ltd, Budapest, Hungary
[4] Semmelweis Univ, Fac Med, Dept Physiol, Budapest, Hungary
[5] Semmelweis Univ, Dept Pharmaceut Chem, Budapest, Hungary
[6] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary
关键词
ADME(T); characterization; compounds; disease; inhibitor; NADPH oxidase 4; relationship; ARTIFICIAL MEMBRANE; LIPOPHILICITY; PERMEABILITY;
D O I
10.2174/157340612800493674
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Through their reactive oxygen species (ROS) producing function, NADPH oxidase (NOX) enzymes have been linked to several oxidative stress related diseases. In our recently published paper [1] we have already shown the NOX4 inhibitory effect of diverse, molecule sub-libraries and their biological importance. We also presented our work connected to potential anti-tumour molecules and the relationship between their biological activity and physico-chemical properties [2]. As an extension of these studies further physico-chemical and biological investigation has been carried out on a molecule group included NOX4 inhibitory chromanone compounds. Here we describe the optimization of early ADME(T) parameters determining lipophilicity, phospholipophilicity and permeability linked to structure-activity relationship. We prove that optimal lipo-and phospholipophilicty can be also determined in case of NOX4 inhibitors and a comparison will be made between the chemically similar isochromanone and chromanone molecular libraries. It will be also shown how to predict the effect of different substituents on permeability, lipo- and phospholipophilicity and also the biological differences between anti-tumour molecules and NOX4 inhibitors according to their penetration ability.
引用
收藏
页码:174 / 181
页数:8
相关论文
共 50 条
  • [11] NADPH Oxidase-4 Maintains Neuropathic Pain after Peripheral Nerve Injury
    Kallenborn-Gerhardt, Wiebke
    Schroeder, Katrin
    Del Turco, Domenico
    Lu, Ruirui
    Kynast, Katharina
    Kosowski, Judith
    Niederberger, Ellen
    Shah, Ajay M.
    Brandes, Ralf P.
    Geisslinger, Gerd
    Schmidtko, Achim
    JOURNAL OF NEUROSCIENCE, 2012, 32 (30): : 10136 - 10145
  • [12] NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload
    Schnelle, Moritz
    Sawyer, Iain
    Anilkumar, Narayana
    Mohamed, Belal A.
    Richards, Daniel A.
    Toischer, Karl
    Zhang, Min
    Catibog, Norman
    Sawyer, Greta
    Mongue-Din, Heloise
    Schroeder, Katrin
    Hasenfuss, Gerd
    Shah, Ajay M.
    CARDIOVASCULAR RESEARCH, 2021, 117 (01) : 178 - 187
  • [13] NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury
    Hecker, Louise
    Vittal, Ragini
    Jones, Tamara
    Jagirdar, Rajesh
    Luckhardt, Tracy R.
    Horowitz, Jeffrey C.
    Pennathur, Subramaniam
    Martinez, Fernando J.
    Thannickal, Victor J.
    NATURE MEDICINE, 2009, 15 (09) : 1077 - U133
  • [14] Nuclear NADPH oxidase-4 associated with disease progression in renal cell carcinoma
    Kaushik, Dharam
    Ashcraft, Keith A.
    Wang, Hanzhang
    Shanmugasundaram, Karthigayan
    Shah, Pankil K.
    Gonzalez, Gabriela
    Nazarullah, Alia
    Tye, Cooper B.
    Liss, Michael A.
    Pruthi, Deepak K.
    Mansour, Ahmed M.
    Chowdhury, Wasim
    Bacich, Dean
    Zhang, Hao
    Watson, Amanda L.
    Block, Karen
    O'Keefe, Denise
    Rodriguez, Ronald
    TRANSLATIONAL RESEARCH, 2020, 223 : 1 - 14
  • [15] NADPH Oxidase-4 Overexpression Is Associated With Epithelial Ciliary Dysfunction in Neutrophilic Asthma
    Wan, Wing-Yan Heidi
    Hollins, Fay
    Haste, Louise
    Woodman, Lucy
    Hirst, Robert A.
    Bolton, Sarah
    Gomez, Edith
    Sutcliffe, Amanda
    Desai, Dhananjay
    Chachi, Latifa
    Mistry, Vijay
    Szyndralewiez, Cedric
    Wardlaw, Andrew
    Saunders, Ruth
    O'Callaghan, Christopher
    Andrew, Peter W.
    Brightling, Christopher E.
    CHEST, 2016, 149 (06) : 1445 - 1459
  • [16] NADPH oxidase-4 and MATER expressions in granulosa cells: Relationships with ovarian aging
    Maraldi, Tullia
    Resca, Elisa
    Nicoli, Alessia
    Beretti, Francesca
    Zavatti, Manuela
    Capodanno, Francesco
    Morini, Dania
    Palomba, Stefano
    La Sala, Giovanni B.
    De Pol, Anto
    LIFE SCIENCES, 2016, 162 : 108 - 114
  • [17] NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury
    Louise Hecker
    Ragini Vittal
    Tamara Jones
    Rajesh Jagirdar
    Tracy R Luckhardt
    Jeffrey C Horowitz
    Subramaniam Pennathur
    Fernando J Martinez
    Victor J Thannickal
    Nature Medicine, 2009, 15 : 1077 - 1081
  • [18] Epigenetic Mechanisms Regulate Nadph Oxidase-4 Expression In Replicative Senescence Of Lung Fibroblasts
    Sanders, Y. Y.
    Liu, H.
    Thannickal, V. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [19] NADPH Oxidase-4 (NOX4) Increases Macrophage Apoptosis Resistance in Pulmonary Fibrosis
    Dhyani, A.
    He, C.
    Larson-Casey, J. L.
    Davis, D.
    Kang, J.
    Gu, L.
    Carter, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [20] The role of cardiomyocyte Nox4D, a redox-active splice variant of NADPH oxidase-4
    Savage, N.
    Anilkumar, N.
    Henckaerts, E.
    Shah, A. M.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2018, 120 : 20 - 20